3 Firms Rep 23andMe's $400M Buy Of Telehealth Biz Lemonaid

By McCord Pagan
October 22, 2021, 3:17 PM EDT

Genetic testing company 23andMe said Friday it's buying telehealth business Lemonaid Health in a $400 million cash-and-stock deal guided by Morgan Lewis & Bockius LLP, Fenwick & West LLP and Nelson Hardiman LLP....

Already a subscriber? Click here to view full article